Asosiy kontentga oʻtish
Boshqa

SYSTEMIC SCLEROSIS AND THE STOMACH

Madiyorov Sh.ETashkent State Medical University, Tashkent, Uzbekistan,Pathogenesis, Clinical Manifestations, Diagnostics, and Modern Treatment Approaches Gastric Involvement in Systemic Sclerosis: PathogenesisSagatova D.RClinical Manifestations, Diagnostics, and Modern Treatment Approaches
ABI

Annotatsiya

Systemic sclerosis (SSc) is a complex autoimmune disease characterized by a triad of widespread microvascular obstruction, immunological disorders, and progressive tissue fibrosis. Internal organ involvement is a major cause of morbidity and mortality. The gastrointestinal tract (GI) is the most commonly affected organ, with GI complications occurring in up to 90% of patients. Gastric pathology is primarily manifested by gastroparesis and Gastric Antral Vascular Ectasia (GAVE). Recent studies have identified an early, active, and potentially reversible immunological myopathy and neuropathy driven by muscarinic M3R antibodies and epigenetic dysregulation of microRNAs. This article reviews the cellular pathogenesis, clinical epidemiology, current diagnostic methods, and treatment approaches of GI obstruction, including relamorelin, IVIG, and the 2024 EULAR guidelines.

Hali tarjima qilinmagan

Identifikatorlar

Iqtiboslar va manbalar

0 ta iqtibos0 ta foydalanilgan manba